Global and Japan Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

Global and Japan Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Pharmaceutical
  • 106 pages

Report Description

Global Anti-obesity Medicine Scope and Market Size
Anti-obesity Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-obesity Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription Drugs
OTC Drugs

Segment by Application
Men
Women

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alizyme
Amylin Pharmaceuticals
Arena Pharmaceuticals
Boehringer Ingelheim
Eisai
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Pfizer
Roche
Merck
Novo Nordisk

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients